Industry / Spain
Spain Wary Over Biogenerics
November 2007 | Industry NewsSpain's Ministry of Health (MoH) is reportedly hesitant to promote biosimilars - generic copies of biotechnology drugs - due to concerns that they do not have bioequivalency to the originator products.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
